Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0001193125-26-294863

Chief Financial Officer acquired 1,541 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Fenton Mary Kay · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-06-30 Grant or award : show line 1 in the form +1,541 $8.60 $13,253 127,921 D
Loading xslF345X06/ownership.xml…